NextSeq 550
The NextSeq 550 System combines tried-and-true next-generation sequencing (NGS) and array capabilities with tunable outputs, enabling both small and large labs to scale to meet their needs. As a foundational instrument in the Illumina NGS system portfolio, the NextSeq 550 System is ideal for labs that want to expand beyond their current capacity and new labs interested in harnessing the complementary powers of sequencing and genotyping on a single instrument (Figure 1).
NextSeq 550
The NextSeq 550 System combines tried-and-true next-generation sequencing (NGS) and array capabilities with tunable outputs, enabling both small and large labs to scale to meet their needs. As a foundational instrument in the Illumina NGS system portfolio, the NextSeq 550 System is ideal for labs that want to expand beyond their current capacity and new labs interested in harnessing the complementary powers of sequencing and genotyping on a single instrument (Figure 1). Its fast DNA-to-results workflow enables rapid sequencing of exomes, targeted panels, and transcriptomes in a single run, with the flexibility to switch to low- or high-throughput sequencing as needed.
| NextSeq 550 System specifications | |
| Parameter | Specification |
| Instrument configuration | RFID tracking for consumables |
| Instrument control computer (Internal)a | Base Unit: Dual Intel Xeon E5-2618L 2.2 GHz CPU Memory: 96 GB RAM
Hard Drive: 750 GB Operating System: Windows 10 enterprise |
| Operating environment | Temperature: 19°C to 25°C (22°C ± 3°C)
Humidity: Noncondensing 20%–80% relative humidity Altitude: Less than 2000 m (6500 ft) Air Quality: Pollution degree rating of II Ventilation: Up to 2048 BTU/hr @ 600 W For Indoor Use Only |
| Light emitting diode (LED) | 520 nm, 650 nm; Laser diode: 780 nm, Class IIIb |
| Dimensions | W × D × H: 53.3 cm × 63.5 cm × 58.4 cm (21.0 in × 25.0 in
× 23.0 in) Weight: 83 kg (183 lb) Crated Weight: 151.5 kg (334 lb) |
Features
2-color SBS chemistry.
Random cluster/bridge amplification.
Run time: 11-29 hrs.
Methylation & cytogenetic microarray
scanning.
Introduced in 2016.
Benefits
RNA sequencing.
Single Cell Applications.
Bacterial & viral (small) genomes.
WGS of small/mid-size non-human genomes (plants/animals).
Targeted regions, amplicon panels (Oncology .).
Clinical Exome (Trusight one extended).
Noninvasive prenatal testing (NIPT, Veriseq V2, Veriseq16).
Cytogenomic (PGS)/methylation array genotyping.
TruSightTM Oncology 500 Portfolio for CGP.
Genotyping by sequencing (GBS)
